VC  SightLine Partners

http://www.sightlinepartners.com





     Office Locations:

8500 Normandale Lake Blvd. Suite 1070
Bloomington, MN 55437
Phone: 952.641.0300
Fax: 952.641.0310

 

Stages:

  • Expansion


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    SightLine Partners is the successor firm to Piper Jaffray Ventures, having acquired the healthcare venture capital operations from Piper Jaffray on December 31, 2004. Sightline Partners' investment strategy is focused on later stage medical device companies that have a near term clarity of exit and provide the best opportunity for risk-adjusted returns in today's medical device industry. The Sightline team currently manages five healthcare funds that have collectively invested in over 70 companies since 1992. The firm's investment size ranges from $2-$8 million depending on the maturity of the company and investments are made throughout the United States. Specifically, the firm focuses investing activities on medical technology companies that are developing proprietary medical devices for treating unmet clinical needs in high value therapeutic areas such as vascular diseases, diabetes, spine, stroke prevention and treatment of pulmonary disease. The firm announced August of 2013 the closing of SightLine Healthcare Opportunity Fund II, L.P., a $107 million Fund dedicated to secondary direct investments in medical technology companies.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Buzz Benson Managing Director
    Joe Biller Managing Director
    Josh Baltzel Venture Partner
    Kunal Paymaster VP
    Scott Ward Managing Director

     

    Portfolio companies include:


      Acorn Cardiovascular


      Anulex
        web link


      Broncus Technologies
        web link


      Conventus Orthopaedics
        web link


      CVRx
        web link


      Endocardial Solutions


      Labcorp
        web link


      Monteris Medical
        web link


      Suros Surgical Systems


      Verax Biomedical
        web link


     

    Recent News: